Leadership Page

Our bench strength.

From leading research minds to extensive market knowledge, our leadership team brings together the expertise and experienced oversight to advance our goal of leveraging cancer breakthroughs to build viable commercial opportunities.

Management

Management

Jeff Courtney, BSc

President

Mr. Jeff Courtney has extensive experience in venture capital, business development and strategic planning. Prior to joining FACIT, Mr. Courtney was Managing Director of Verde Ventures...


David O’Neill, PhD

Vice President, Business Development

Dr. David O’Neill joined FACIT in 2013 and is responsible for start-up company corporate strategy and pharmaceutical partnerships. He brings a wealth of networks and experience...


Nicole Baryla, PhD

Director, Alliance and Project Management

Dr. Nicole Baryla joined the FACIT team with 12 years combined experience in not-for-profit organizations, biotech start-up companies, the pharmaceutical industry, and academic research settings...


Connie Chen, PhD

Director, Business Intelligence and Strategy

Dr. Connie Chen joined FACIT in 2013 with over 12 years of experience in the life sciences, biotechnology and capital markets sectors. Several leadership roles in both the corporate world as well as in the capital markets...


Frank Gleeson, BBA, MBA

Executive-in-Residence

Mr. Frank Gleeson has more than 20 years of leadership and business building experience as an operating executive and venture capitalist. During his career, he has completed more than $300 million...


David Koehler, PhD, CLP

Director, Fund Operations

Dr. David Koehler joined OICR’s Commercialization group in 2007.  His responsibilities include managing the Intellectual Property Development and Commercialization (IPDC) Fund...


Robert M. Sutherland, BSc, PhD

Senior Investment Advisor

Dr. Robert Sutherland facilitates and advises FACIT in the identification of projects for early stage development and the engagement of market receptors and investor groups...


Brent Zanke, MD, FRCPC, PhD

Executive-in-Residence

Dr. Brent Zanke consults widely on matters of biomarkers, laboratory molecular pathology, innovation policy and health care delivery systems...


Board of Trustees

Board of Trustees

Gregory D. Gubitz, BA, LLB

Mr. Gregory Gubitz is a seasoned life science executive and business lawyer, with significant transaction, investment and operating experience...

John Morrison, BSc

Mr. John Morrison is a retired chief executive and has been an active corporate director of leading companies and voluntary organizations. He has been responsible for operations in Canada, the U.S., Europe and Asia...

Douglas Squires, PhD

Dr. Douglas Squires was CEO and Chairman of the Board of Biovail Corporation, then Canada’s largest publically traded pharmaceutical company. During his tenure, he executed a major change in strategic...